ARCALYST® (rilonacept) exemplifies Regeneron's commitment to discover, develop, and commercialize important medicines for patients
suffering from serious diseases.
Regeneron Pharmaceuticals, Inc. currently markets ARCALYST Injection for Subcutaneous Use in the U.S. for the treatment of a rare, inherited, inflammatory condition.
Highlights
For further information about ARCALYST, call 1-877-REGN-777 (1-877-734-6777)